Aardvark Therapeutics, Inc.
AARDFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Aardvark Therapeutics, Inc. Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 2 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Feb 11, 2026.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Aardvark Therapeutics, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2025-02-14 · Cormorant Asset Management, LP: Larger than 10 of the 11 other insider purchases of Common Stock on file. SEC filing
- 2025-02-14 · Cui Xiangmin: Larger than all 11 other insider purchases of Common Stock on file. SEC filing
Independent insiders buying near the same time
- 2025-12-11–2025-12-11: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2025-09-09–2025-09-15: 6 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing )
- 2025-02-14–2025-02-14: 4 event(s) across 4 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2025-12-11 | Sun Nelson · Chief Financial Officer | Common Stock | P — Open market or private purchase | +3,000 | 14.40 | SEC filing |
| 2025-12-11 | Lee Tien-Li · Chief Executive Officer | Common Stock | P — Open market or private purchase | +7,000 | 14.49 | SEC filing |
| 2025-09-15 | Lee Tien-Li · Chief Executive Officer | Common Stock | P — Open market or private purchase | +6,500 | 9.51 | SEC filing |
| 2025-09-15 | Lee Tien-Li · Chief Executive Officer | Common Stock | P — Open market or private purchase | +3,500 | 9.94 | SEC filing |
| 2025-09-12 | Lee Tien-Li · Chief Executive Officer | Common Stock | P — Open market or private purchase | +5,000 | 8.50 | SEC filing |
| 2025-09-11 | Lee Tien-Li · Chief Executive Officer | Common Stock | P — Open market or private purchase | +6,000 | 7.82 | SEC filing |
| 2025-09-10 | Lee Tien-Li · Chief Executive Officer | Common Stock | P — Open market or private purchase | +9,000 | 7.91 | SEC filing |
| 2025-09-09 | Sun Nelson · Chief Financial Officer | Common Stock | P — Open market or private purchase | +6,000 | 8.07 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-02-09 | Jaiman Manasi · Chief Medical Officer | Stock option (right to buy) | A — Grant, award, or other acquisition | −70,549 | SEC filing |
| 2026-02-09 | Lee Tien-Li · Chief Executive Officer | Stock option (right to buy) | A — Grant, award, or other acquisition | −203,851 | SEC filing |
| 2026-02-09 | Sun Nelson · Chief Financial Officer | Stock option (right to buy) | A — Grant, award, or other acquisition | −70,549 | SEC filing |
| 2025-10-15 | Lee Tien-Li · Chief Executive Officer | Stock option (right to buy) | M — Exercise or conversion of derivative security | −1,229 | SEC filing |
| 2025-10-15 | Jones Bryan · Chief Operating Officer | Stock option (right to buy) | M — Exercise or conversion of derivative security | −1,250 | SEC filing |
| 2025-10-15 | Lee Tien-Li · Chief Executive Officer | Common Stock | M — Exercise or conversion of derivative security | +1,229 | SEC filing |
| 2025-10-15 | Jones Bryan · Chief Operating Officer | Common Stock | M — Exercise or conversion of derivative security | +1,250 | SEC filing |
| 2025-08-28 | Lee Tien-Li · Chief Executive Officer | Common Stock | M — Exercise or conversion of derivative security | +17,209 | SEC filing |
Showing 8 of 20 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.